Bio-Kinetic Clinical Applications Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
60
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Bio-Kinetic Clinical Applications General Information
Description
Provider of Phase I clinical study services. The company designs and conducts Phase I clinical studies for branded pharmaceutical, bio-technology, and generic drug companies. It owns and operates a 240-bed Phase I facility in Springfield, Missouri. Its services include protocol development, phase I and III clinical pharmacology, safety and tolerance studies, bioequivalence/bioavailability, pharmacokinetic/pharmacodynamic, drug/drug interaction, food effect, QTC intervals, rising dose tolerance, and data management.
Contact Information
Primary Office
- 1816 West Mount Vernon Street
- Springfield, MO 65802
- United States
+1 (417) 000-0000
Bio-Kinetic Clinical Applications Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bio-Kinetic Clinical Applications Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Dave Koenigsfeld | Chief Operating Officer & Chief Information Officer |
Bio-Kinetic Clinical Applications Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Bio-Kinetic Clinical Applications Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|